ARRY Stock Chart

ARRAY BIOPHARMA INC

 

ARRY

Channibal Channibal PRO ARRY, D, Long , 2 months ago
ARRY: ARRY - Long - Swing
43 0 1
ARRY, D Long
ARRY - Long - Swing
+ Broke out earlier this week on very high volume + Prices retraced back towards the rising 5ema + Broke-out again with but on very low volume - upper shadow on Friday's bar - the range of sideway move over the past few days were a bit too wide, subject to volatility (& chopped) even if successful break-out ...
Tecnologia_Financiera Tecnologia_Financiera ARRY, 15, Long , 2 months ago
ARRY: ARRY MOMENTUM SCALP
37 0 2
ARRY, 15 Long
ARRY MOMENTUM SCALP
ARRY MOMENTUM SCALP
AntonioNaVi AntonioNaVi PRO ARRY, D, Long , 2 months ago
ARRY: breakout formation >3.76
74 0 6
ARRY, D Long
breakout formation >3.76
LONG >3.76 STOP 3.65 TARGET 4 - 4.28 - 4.5
Rusario Rusario ARRY, D, Long , 3 months ago
ARRY: Long ARRY
32 0 2
ARRY, D Long
Long ARRY
It looks like is bouncing on uptrend support.
NaughtyPines NaughtyPines ARRY, D, 3 months ago
ARRY: TRADE IDEA: ARRY COVERED CALL
12 0 1
ARRY, D
TRADE IDEA: ARRY COVERED CALL
Metrics: Buy 100 Shares at 3.23 Sell Oct 21st 4 call 2.83 db at the mid (i.e., 2.83 is your cost basis in the shares) Max Profit: $117 (if called away at 4) ROC: 41% ROC Notes: A good spot to initiate this here, given a bit of horizontal support.
NaughtyPines NaughtyPines AMRN, D, 4 months ago
AMRN: COVERED CALL CANDIDATES: AMRN, ARRY, FOLD
24 0 2
AMRN, D
COVERED CALL CANDIDATES: AMRN, ARRY, FOLD
AMRN at 3.33/share; sell Sept 16th 3.5 call; 2.75 db; max profit $75 (21.4% ROC). FOLD at 7.00/share; sell Sept 16th 7 call; 6.20 debit; max profit $80 (12.9% ROC). ARRY at 4.54/share; sell Sept 16th 5 call; 4.19 db; max profit $81 (19.3% ROC). Notes: Preliminary/off hours. I would also note I haven't looked at ...
DATAUNION DATAUNION ARRY, D, 4 months ago
ARRY: ARRY Correlation Histogram
13 0 1
ARRY, D
ARRY Correlation Histogram
Correlation Histogram Type indication
pkonikowski pkonikowski ARRY, D, Long , 4 months ago
ARRY: $ARRY Will The Short Squeeze Continue on Array Biopharma?
25 0 2
ARRY, D Long
$ARRY Will The Short Squeeze Continue on Array Biopharma?
With Array Biopharma earnings this week, the chance of another short squeeze increases, but so does your risk. Golden Cross on Daily, positive divergence on MACD, riding the upper Bollinger Band as of 8/2. My $ARRY upside target is $5.47 NASDAQ:ARRY
Aiming Aiming ARRY, D, Long , 6 months ago
ARRY: let it to be corrected little.
32 0 1
ARRY, D Long
let it to be corrected little.
Weekly should cross zero line soon
Aiming Aiming ARRY, D, Long , 6 months ago
ARRY: Now time for break out
11 0 0
ARRY, D Long
Now time for break out
Can't wait for ASCO
Aiming Aiming ARRY, D, Long , 6 months ago
ARRY: Let Awsome Osc to cross zero line
9 0 0
ARRY, D Long
Let Awsome Osc to cross zero line
MACD, DMI, RSI & PSAR support signal this
pkonikowski pkonikowski ARRY, D, Long , 7 months ago
ARRY: ARRY possible short squeeze
18 0 1
ARRY, D Long
ARRY possible short squeeze
Shorts need to cover, not enough shares. Earnings around the corner
pkonikowski pkonikowski ARRY, 60, Long , 7 months ago
ARRY: ARRY Short Squeeze Potential
8 0 1
ARRY, 60 Long
ARRY Short Squeeze Potential
Watch for key breaks
YoungMula YoungMula ARRY, D, Short , 11 months ago
ARRY: Short Continuation
31 0 1
ARRY, D Short
Short Continuation
Mentioned a possible dead cat bounce on 12/14 playing out as expected
YoungMula YoungMula ARRY, D, a year ago
ARRY: Potential Dead Cat Bounce
22 0 1
ARRY, D
Potential Dead Cat Bounce
Price could bounce up to 4.50 from here where overhead supply will probably knock it ultimately down to $3.00
ersoytoptas ersoytoptas PRO ARRY, W, Long , 2 years ago
ARRY: ARRAY  UP LONG  PART(1)
126 0 4
ARRY, W Long
ARRAY UP LONG PART(1)
financial results for the second quarter of fiscal 2015 and hold a conference call to discuss those results on Tuesday, February 3, 2015.

News

Fundamentals ARRY

Price History
Average Volume ---
Beta - 1 Year ---
Price - 52 Week High ---
Price - 52 Week Low ---
Valuation
Enterprise Value/EBITDA, TTM ---
Enterprise Value, FQ ---
Market Cap - Basic ---
Number of Employees ---
Number of Shareholders ---
Price/Earnings, TTM ---
Price/Revenue, TTM ---
Dividends
Dividends Paid ---
Dividends per Share, FQ ---
Expected Annual Dividends ---
Margins
After-tax Margin ---
Gross Margin ---
Gross Margin %, TTM ---
Operating Margin ---
Pre-tax Margin ---
Balance Sheet
Cash Ratio ---
Current Ratio ---
Debt to Assets ---
Debt to Equity ---
Long Term Capital ---
Net Debt ---
Quick Ratio ---
Total Assets ---
Total Capital ---
Total Debt ---
Income Statement
Basic EPS, Net Income ---
Earnings per Share, Basic, TTM ---
EBITDA ---
Gross Profit ---
Last Annual EPS ---
Last Annual Revenue ---
Net Income ---
Total Revenue ---
Operating Metrics
Return on Assets ---
Return on Equity ---
Return on Invested Capital ---
Return on Invested Capital %, TTM ---
Revenue per Employee ---
Market
Interval
Browse
Time
Author
Widgets
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out